PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions (PREPARE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03093818
Recruitment Status : Recruiting
First Posted : March 28, 2017
Last Update Posted : October 2, 2018
University of Liverpool
Medical University of Vienna
Centro di Riferimento Oncologico - Aviano
Andaluz Health Service
University of Patras
University of Ljubljana
Karolinska Institutet
The Golden Helix Foundation
Royal Dutch Pharmacists Association (KNMP)
Bio.Logis Genetic Information Management
Paul Sabatier University
Uppsala University
Robert Bosch Gesellschaft für Medizinische Forschung mbH
Federal Institute for Drugs and Medical Devices
St. Antonius Hospital
Information provided by (Responsible Party):
J.J.Swen, Leiden University Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2019
  Estimated Study Completion Date : December 2019